[What can be expected from biological therapies for Crohn's disease?].

Lemann, M

[What can be expected from biological therapies for Crohn's disease?]. [electronic resource] - Gastroenterologie clinique et biologique Nov 2001 - 945-7 p. digital

Publication Type: Comment; Editorial; Review

0399-8320


Antibodies, Monoclonal--adverse effects
Anus Diseases--drug therapy
Crohn Disease--complications
Gastrointestinal Agents--adverse effects
Humans
Infliximab
Tumor Necrosis Factor-alpha--immunology